RMD logo

RMD
Resmed Inc.

2,060
Mkt Cap
$48.38B
Volume
952,387.00
52W High
$293.81
52W Low
$199.92
PE Ratio
26.36
RMD Fundamentals
Price
$252.39
Prev Close
$257.61
Open
$255.66
50D MA
$250.56
Beta
0.78
Avg. Volume
917,649.32
EPS (Annual)
$9.51
P/B
6.14
Rev/Employee
$485,502.55
Loading...
Loading...
News
all
press releases
Wells Fargo & Company Forecasts Strong Price Appreciation for ResMed (NYSE:RMD) Stock
Wells Fargo & Company increased their price target on ResMed from $265.00 to $270.00 and gave the stock an "equal weight" rating in a report on Friday...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
ResMed Inc. (NYSE:RMD) Declares Quarterly Dividend of $0.60
ResMed Inc. (NYSE:RMD) announced a quarterly dividend on Thursday, January 29th. Investors of record on Thursday, February 12th will be paid a dividend of 0.60 per share by the medical equipment...
MarketBeat·3h ago
News Placeholder
Meridian Management Co. Buys Shares of 9,221 ResMed Inc. $RMD
Meridian Management Co. purchased a new position in ResMed Inc. (NYSE:RMD - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission...
MarketBeat·6h ago
News Placeholder
Pittenger & Anderson Inc. Has $26.81 Million Stock Holdings in ResMed Inc. $RMD
Pittenger & Anderson Inc. boosted its holdings in ResMed Inc. (NYSE:RMD - Free Report) by 4.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·6h ago
News Placeholder
Tandem Investment Advisors Inc. Grows Stock Holdings in ResMed Inc. $RMD
Tandem Investment Advisors Inc. boosted its holdings in shares of ResMed Inc. (NYSE:RMD - Free Report) by 1.5% in the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·6h ago
News Placeholder
AlphaQuest LLC Grows Stock Position in ResMed Inc. $RMD
AlphaQuest LLC raised its position in ResMed Inc. (NYSE:RMD - Free Report) by 1,038.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and...
MarketBeat·10h ago
News Placeholder
ResMed Q2 Earnings Call Highlights
ResMed (NYSE:RMD) executives highlighted revenue growth, margin expansion and continued investment in product development and demand-generation initiatives during the company's second quarter fiscal...
MarketBeat·12h ago
News Placeholder
ResMed (RMD) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for ResMed (RMD) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·20h ago
News Placeholder
ResMed (RMD) Q2 Earnings and Revenues Beat Estimates
ResMed (RMD) delivered earnings and revenue surprises of +4.59% and +2.30%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·20h ago
News Placeholder
ResMed (NYSE:RMD) Issues Quarterly Earnings Results
ResMed (NYSE:RMD - Get Free Report) posted its earnings results on Thursday. The medical equipment provider reported $2.81 EPS for the quarter, topping the consensus estimate of $2.68 by $0.13. The...
MarketBeat·21h ago
<
1
2
...
>

Latest RMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.